American Century Companies’s Ginkgo Bioworks DNA Stock Holding History

American Century Companies's DNA Position: Q1 2026 in Review

American Century Companies reduced its Ginkgo Bioworks (DNA) stake by 1% in Q1 2026, selling an estimated $7.56K and leaving 87,386 shares worth $536K. The position accounts for ﹤0.01% of the portfolio, ranked #2497.

American Century Companies first reported a position in DNA in Q2 2022 and has held it in 11 quarters since. The position peaked at $1.17M in Q3 2025. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

• American Century Companies held 87,386 shares of Ginkgo Bioworks worth $536K as of Q1 2026.
• American Century Companies sold 909 Ginkgo Bioworks shares in Q1 2026, an estimated $7.56K.
• Ginkgo Bioworks made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2497 holding.
• American Century Companies first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 11 quarters since.
• American Century Companies's Ginkgo Bioworks position peaked at $1.17M in Q3 2025.
• 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.